Effects of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Cumulus Cells Following In Vitro Fertilization (IVF)/Intra-Cytoplasmic Sperm Injection (ICSI) Treatment-A Systematic Review

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Jun 28

PMID 37374020

Authors

Woon Shu Yuan

Muhammad Azrai Abu

Mohd Faizal Ahmad

Marjanu Hikmah Elias

Abdul Kadir Abdul Karim

Affiliations

Soon will be listed here.

Abstract

Despite many studies exploring the effects of DHEA supplementation, its application in IVF procedure continues to be a subject of debate owing to the inconsistent findings and the lack of rigorously designed, large-scale, randomized trials. Our review aims to explore the effectiveness of DHEA supplementation in ovarian cumulus cells following IVF/ICSI treatment. We conducted a literature search of Pub-Med, Ovid MEDLINE, and SCOPUS (inception to June 2022) for all relevant articles, including the keywords of "dehydroepiandrosterone/DHEA", "oocyte", and "cumulus cells". From the preliminary search, 69 publications were identified, and following a thorough screening process, seven studies were ultimately incorporated into the final review. Four hundred twenty-four women were enrolled in these studies, with DHEA supplementation being administered exclusively to women exhibiting poor ovarian response/diminished ovarian reserve or belonging to an older age demographic. The intervention in the studies was DHEA 75-90 mg daily for at least 8-12 weeks. The only randomized controlled trial showed no difference in clinical or cumulus cell-related outcomes between the control and treatment groups. However, the remaining six studies (two cohorts, four case-controls) showed significant beneficial effects of DHEA in cumulus cell-related outcomes compared to the group (older age or POR/DOR) without DHEA supplementation. All studies revealed no significant difference in stimulation and pregnancy outcomes. Our review concludes that DHEA supplementation did show beneficial effect on ovarian cumulus cells in improving oocyte quality for women of advanced age or with poor ovarian responders.

Citing Articles

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.

Naik S, Lepine S, Nagels H, Siristatidis C, Kroon B, McDowell S Cochrane Database Syst Rev. 2024; 6:CD009749.

PMID: 38837771 PMC: 11152211. DOI: 10.1002/14651858.CD009749.pub3.

References

Narkwichean A, Maalouf W, Baumgarten M, Polanski L, Raine-Fenning N, Campbell B . Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial. Eur J Obstet Gynecol Reprod Biol. 2017; 218:39-48. DOI: 10.1016/j.ejogrb.2017.09.006. View

Li C, Lin L, Tsui K . Dehydroepiandrosterone Shifts Energy Metabolism to Increase Mitochondrial Biogenesis in Female Fertility with Advancing Age. Nutrients. 2021; 13(7). PMC: 8308577. DOI: 10.3390/nu13072449. View

Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L . ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26(7):1616-24. DOI: 10.1093/humrep/der092. View

Burger H . Androgen production in women. Fertil Steril. 2002; 77 Suppl 4:S3-5. DOI: 10.1016/s0015-0282(02)02985-0. View

Lin L, Wang P, Chen S, Li C, Wen Z, Cheng J . Protection of cumulus cells following dehydroepiandrosterone supplementation. Gynecol Endocrinol. 2016; 33(2):100-104. DOI: 10.1080/09513590.2016.1214262. View

Wang Z, Yang A, Bao H, Wang A, Deng X, Xue D . Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: A randomised controlled trial. BJOG. 2021; 129(7):1030-1038. DOI: 10.1111/1471-0528.17045. View

Weil S, Vendola K, Zhou J, Adesanya O, Wang J, Okafor J . Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab. 1998; 83(7):2479-85. DOI: 10.1210/jcem.83.7.4917. View

Shen Q, Chen M, Zhao X, Liu Y, Ren X, Zhang L . Versican expression level in cumulus cells is associated with human oocyte developmental competence. Syst Biol Reprod Med. 2020; 66(3):176-184. DOI: 10.1080/19396368.2020.1725685. View

Yeung T, Chai J, Li R, Lee V, Ho P, Ng E . A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. BJOG. 2015; 123(7):1097-105. DOI: 10.1111/1471-0528.13808. View

10.

Hu Q, Hong L, Nie M, Wang Q, Fang Y, Dai Y . The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. J Ovarian Res. 2017; 10(1):32. PMC: 5418866. DOI: 10.1186/s13048-017-0326-3. View

11.

Artini P, Simi G, Ruggiero M, Pinelli S, Di Berardino O, Papini F . DHEA supplementation improves follicular microenviroment in poor responder patients. Gynecol Endocrinol. 2012; 28(9):669-73. DOI: 10.3109/09513590.2012.705386. View

12.

Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelley C . A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995; 92(20):9363-7. PMC: 40985. DOI: 10.1073/pnas.92.20.9363. View

13.

Zangmo R, Singh N, Kumar S, Vanamail P, Tiwari A . Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles. Reprod Biomed Online. 2014; 28(6):743-7. DOI: 10.1016/j.rbmo.2014.01.019. View

14.

Xiong S, Mu T, Wang G, Jiang X . Mitochondria-mediated apoptosis in mammals. Protein Cell. 2014; 5(10):737-49. PMC: 4180462. DOI: 10.1007/s13238-014-0089-1. View

15.

Sonmezer M, Ozmen B, Cil A, Ozkavukcu S, Tasci T, Olmus H . Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reprod Biomed Online. 2009; 19(4):508-13. DOI: 10.1016/j.rbmo.2009.06.006. View

16.

Casson P, Santoro N, Elkind-Hirsch K, Carson S, Hornsby P, Abraham G . Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril. 1998; 70(1):107-10. DOI: 10.1016/s0015-0282(98)00121-6. View

17.

Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A . Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod. 2010; 25(10):2496-500. DOI: 10.1093/humrep/deq220. View

18.

Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L . Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002; 77(4):660-5. DOI: 10.1016/s0015-0282(02)02969-2. View

19.

Roy M, Vom A, Czabotar P, Lessene G . Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway. Br J Pharmacol. 2013; 171(8):1973-87. PMC: 3976616. DOI: 10.1111/bph.12431. View

20.

Hartmann B, Kirchengast S, Albrecht A, Laml T, Soregi G, Huber J . Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest. 1997; 44(2):127-31. DOI: 10.1159/000291503. View